Skip to main content
Clinical Trials/NCT02963194
NCT02963194CompletedNot Applicable

Oxytocin Effects on Self and Other Processing

University of Electronic Science and Technology of China1 site in 1 country44 target enrollmentStarted: November 2015Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
44
Locations
1
Primary Endpoint
Compared the indifference point between buy and sell conditions during the price phase and the specific brain region activation between oxytocin and placebo groups

Study Overview

Brief Summary

To determine whether the neuropeptide oxytocin (OXT) influences self-processing by investigating whether it increases the endowment effect in relation to both self and others.

Detailed Description

In a double-blind, between- subject placebo (PLC) controlled design, investigator aimed to measure the effect of intranasal OXT on the endowment effect. All subjects completed a range of questionnaires measuring personality and affective traits and levels of anxiety before self-administration: Positive and Negative Affect Schedule (PANAS) , State-Trait Anxiety Inventory (STAI) , Beck Depression Inventory (BDI), self-esteem scale (SES). Subjects were asked to decide whether to buy or sell their own or others' (their mothers'/ fathers'/ classmate'/ strangers') possessions at various prices. Indifference point and brain activation were inluded into analysis as dependent variables.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Basic Science
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to 27 Years (Adult)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • healthy subjects without past or current psychiatric or neurological disorders

Exclusion Criteria

  • history of head injury;
  • claustrophobia;
  • medical or psychiatric illness.

Arms & Interventions

Oxytocin

Experimental

Oxytoxin nasal spray

Intervention: Oxytocin (Drug)

Placebo

Placebo Comparator

Placebo nasal spray

Intervention: Placebo (Drug)

Outcomes

Primary Outcomes

Compared the indifference point between buy and sell conditions during the price phase and the specific brain region activation between oxytocin and placebo groups

Time Frame: 1 hour

Indifference point is the gap between willingness to accept and willingness to pay ;focus on the specfic brain region relasted to self-processing, such as medial prefrontal cortex, precuneus, posterior cingulate cortex, ventral striatum.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
University of Electronic Science and Technology of China
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Oxytocin Effects on Self and Other... | Clinical Trial